{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T05:40:37Z","timestamp":1736314837551,"version":"3.32.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bulcan.2024.07.008","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T11:26:27Z","timestamp":1725276387000},"page":"S10-S23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S","title":["Aplasies m\u00e9dullaires s\u00e9v\u00e8res acquises dans les pays \u00e9mergents\u00a0: prise en charge d\u00e8s l\u2019indication de l\u2019allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques jusqu\u2019au suivi postgreffe (SFGM-TC)"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0576-2800","authenticated-orcid":false,"given":"Nabil","family":"Yafour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Amine","family":"Bekadja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibtissam","family":"El Bejjaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"El-Cheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"El Kababri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9onardo","family":"Magro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fati","family":"Hamzy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bulcan.2024.07.008_bib0435","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2009.07842.x","article-title":"Guidelines for the diagnosis and management of aplastic anaemia","volume":"147","author":"Marsh","year":"2009","journal-title":"Br J Haematol"},{"year":"2024","author":"Peffault de Latour","series-title":"Acquired bone marrow failure: severe aplastic anemia and paroxysmal nocturnal hemoglobinuria. The EBMT Handbook","key":"10.1016\/j.bulcan.2024.07.008_bib0440"},{"issue":"12","key":"10.1016\/j.bulcan.2024.07.008_bib0445","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1182\/bloodadvances.2021004345","article-title":"Approach to the diagnosis of aplastic anemia","volume":"5","author":"DeZern","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.008_bib0450","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood.V48.1.63.63","article-title":"Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality","volume":"48","author":"Camitta","year":"1976","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.008_bib0455","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/bmt.2012.230","article-title":"Diagnosis of acquired aplastic anemia","volume":"48","author":"Rov\u00f3","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.008_bib0460","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2141.1988.tb02460.x","article-title":"Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party","volume":"70","author":"Bacigalupo","year":"1988","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.bulcan.2024.07.008_bib0465","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2016-08-693481","article-title":"How I treat acquired aplastic anemia","volume":"129","author":"Bacigalupo","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.008_bib0470","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1182\/asheducation-2016.1.90","article-title":"Transplantation for bone marrow failure: current issues","volume":"2016","author":"Peffault de Latour","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"issue":"10","key":"10.1016\/j.bulcan.2024.07.008_bib0475","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1038\/s41409-021-01332-8","volume":"56","author":"Iftikhar","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.008_bib0480","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/16078454.2019.1711344","article-title":"Epidemiology of aplastic anemia: a study of 1324\u00a0cases","volume":"25","author":"Ahmed","year":"2020","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.008_bib0485","first-page":"102","article-title":"Epidemiology of acquired aplastic anaemia in Pakistan","volume":"23","author":"Ehsan","year":"2011","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"10","key":"10.1016\/j.bulcan.2024.07.008_bib0490","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1007\/s00277-021-04566-0","article-title":"Adult aplastic anemia in Thailand: incidence and treatment outcome from a prospective nationwide population-based study","volume":"100","author":"Norasetthada","year":"2021","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.008_bib0495","doi-asserted-by":"crossref","first-page":"E86","DOI":"10.1002\/ajh.25388","article-title":"High frequency of acquired aplastic anemia in Tanzania","volume":"94","author":"Ally","year":"2019","journal-title":"Am J Hematol"},{"issue":"Suppl. 1","key":"10.1016\/j.bulcan.2024.07.008_bib0500","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1182\/blood-2018-99-114094","article-title":"Epidemiological study of aplastic anemia in Algeria for 844\u00a0cases over 10\u00a0years (2007-2016)","volume":"132","author":"Mehdid","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.008_bib0505","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/17474086.2023.2191946","article-title":"Hematopoietic cell transplants in resource-poor countries: challenges and opportunities","volume":"16","author":"Jaimovich","year":"2023","journal-title":"Exp Rev Hematol"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.008_bib0510","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.hemonc.2017.05.019","article-title":"Hematopoietic stem cell transplantation in Algeria","volume":"10","author":"Bekadja","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.008_bib0515","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00277-020-03914-w","article-title":"Two decades of experience in a combined adult\/pediatric allogeneic hematopoietic stem cell transplantation center in Algiers, Algeria","volume":"99","author":"Benakli","year":"2020","journal-title":"Ann Hematol"},{"issue":"Suppl. 1","key":"10.1016\/j.bulcan.2024.07.008_bib0520","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1038\/bmt.2008.143","article-title":"Allogeneic hematopoietic stem cell transplantation in Tunisia","volume":"42","author":"Ben Othman","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.008_bib0525","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/bmt.2013.231","article-title":"Allogeneic hematopoietic stem cell transplantation for acquired aplastic anemia using cyclophosphamide and antithymocyte globulin: a single center experience","volume":"49","author":"Ladeb","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.008_bib0530","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.thj.6200246","article-title":"Bone marrow transplantation for patients with acquired severe aplastic anemia using cyclophosphamide and antithymocyte globulin: the experience from a single center","volume":"4","author":"Abdelkefi","year":"2003","journal-title":"Hematol J"},{"issue":"Suppl. 1\u20132","key":"10.1016\/j.bulcan.2024.07.008_bib0535","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1038\/bmt.2008.130","article-title":"Present and future of hematology and stem cell transplantation in Morocco","volume":"42","author":"Benchekroun","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.008_bib0540","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.hemonc.2017.05.003","article-title":"Trends in hematopoietic stem cell transplant activity in Lebanon","volume":"10","author":"Bazarbachi","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.008_bib0545","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s15010-020-01407-6","article-title":"Pre-engraftment infectious complications and patient outcomes after allogeneic hematopoietic cell transplantation: a single-center experience from Lebanon","volume":"48","author":"Moghnieh","year":"2020","journal-title":"Infection"},{"issue":"Suppl. 1","key":"10.1016\/j.bulcan.2024.07.008_bib0550","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1038\/bmt.2008.137","article-title":"The stem cell transplant program in Pakistan\u00a0\u2013\u00a0the first decade","volume":"42","author":"Shamsi","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.008_bib0555","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.hemonc.2017.05.026","article-title":"Hematopoietic stem cell transplantation in Pakistan - country report","volume":"10","author":"Ahmed","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"11S","key":"10.1016\/j.bulcan.2024.07.008_bib0560","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.bulcan.2016.09.006","article-title":"[How we harmonize HSCT clinical practices among the SFGM-TC centers]","volume":"103","author":"Tipton","year":"2016","journal-title":"Bull Cancer"},{"issue":"8580","key":"10.1016\/j.bulcan.2024.07.008_bib0565","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(88)90388-1","article-title":"Criteria for severe aplastic anaemia","volume":"1","author":"Camitta","year":"1988","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bulcan.2024.07.008_bib0570","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3324\/haematol.2011.050096","article-title":"Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning","volume":"97","author":"Konopacki","year":"2012","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.008_bib0575","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/bmt.2012.223","article-title":"Standard treatment of acquired SAA in adult patients 18-40\u00a0years old with an HLA-identical sibling donor","volume":"48","author":"Aljurf","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.008_bib0580","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12865-020-0340-x","article-title":"Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis","volume":"21","author":"Zhu","year":"2020","journal-title":"BMC Immunol"},{"issue":"12","key":"10.1016\/j.bulcan.2024.07.008_bib0585","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.3324\/haematol.2010.026682","article-title":"Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors","volume":"95","author":"Gupta","year":"2010","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.bulcan.2024.07.008_bib0590","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJMoa1103975","article-title":"Horse versus rabbit antithymocyte globulin in acquired aplastic anemia","volume":"365","author":"Scheinberg","year":"2011","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.bulcan.2024.07.008_bib0595","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1182\/blood-2012-02-407684","article-title":"Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party","volume":"119","author":"Marsh","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.008_bib0600","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa2109965","article-title":"Eltrombopag added to immunosuppression in severe aplastic anemia","volume":"386","author":"Peffault de Latour","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.008_bib0605","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S2352-3026(23)00395-2","article-title":"Activity and safety of eltrombopag in combination with cyclosporin A as first-line treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study","volume":"11","author":"Scheinberg","year":"2024","journal-title":"Lancet Haematol"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.008_bib0610","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3324\/haematol.2017.176339","article-title":"Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia","volume":"103","author":"Lengline","year":"2018","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.008_bib0615","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.bbmt.2019.01.015","article-title":"Consider allogeneic bone marrow transplantation for older, FitPatients with aplastic anemia","volume":"25","author":"Georges","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.008_bib0620","first-page":"321","article-title":"Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation","volume":"111","author":"Kojima","year":"2000","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.bulcan.2024.07.008_bib0625","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jama.289.9.1130","article-title":"Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome","volume":"289","author":"Rosenfeld","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.bulcan.2024.07.008_bib0630","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ajh.25050","article-title":"Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia","volume":"93","author":"Peffault de Latour","year":"2018","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.008_bib0635","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2141.2012.09066.x","article-title":"Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience","volume":"157","author":"Samarasinghe","year":"2012","journal-title":"Br J Haematol"},{"issue":"20","key":"10.1016\/j.bulcan.2024.07.008_bib0640","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1182\/bloodadvances.2019000480","article-title":"Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50\u00a0years","volume":"3","author":"Sheth","year":"2019","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.008_bib0645","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bjh.13614","volume":"171","author":"Dufour","year":"2015","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.bulcan.2024.07.008_bib0650","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/bloodadvances.2020001729","article-title":"Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide","volume":"4","author":"DeZern","year":"2020","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.bulcan.2024.07.008_bib0655","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/s41409-019-0773-0","article-title":"Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party","volume":"55","author":"Prata","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.008_bib0660","doi-asserted-by":"crossref","first-page":"105e1","DOI":"10.1016\/j.jtct.2021.10.006","volume":"28","author":"Alotaibi","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"9","key":"10.1016\/j.bulcan.2024.07.008_bib0665","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.bbmt.2018.05.015","article-title":"Unmanipulated haploidentical hematopoietic stem cell transplantation achieved outcomes comparable with matched unrelated donor transplantation in young acquired severe aplastic anemia","volume":"24","author":"Lu","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.008_bib0670","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood.V84.3.941.941","article-title":"Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia","volume":"84","author":"Storb","year":"1994","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bulcan.2024.07.008_bib0675","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2011-12-274019","article-title":"How I treat acquired aplastic anemia","volume":"120","author":"Scheinberg","year":"2012","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.bulcan.2024.07.008_bib0680","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1182\/bloodadvances.2019000722","article-title":"Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia","volume":"3","author":"Bejanyan","year":"2019","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.008_bib0685","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2141.2006.06019.x","article-title":"Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation","volume":"133","author":"Srinivasan","year":"2006","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.bulcan.2024.07.008_bib0690","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1182\/blood-2006-10-052308","article-title":"Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens","volume":"109","author":"Champlin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2024.07.008_bib0695","doi-asserted-by":"crossref","first-page":"100772","DOI":"10.1016\/j.blre.2020.100772","article-title":"Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies","volume":"47","author":"Iftikhar","year":"2021","journal-title":"Blood Rev"},{"issue":"8","key":"10.1016\/j.bulcan.2024.07.008_bib0700","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1182\/blood-2010-12-327536","article-title":"Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia","volume":"118","author":"Marsh","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.008_bib0705","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.bulcan.2024.07.008_bib0710","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/bloodadvances.2020001729","article-title":"Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide","volume":"4","author":"DeZern","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.008_bib0715","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbmt.2016.12.628","article-title":"Alternative donor transplantation with high-dose post-transplantation cyclophosphamide for refractory severe aplastic anemia","volume":"23","author":"DeZern","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.bulcan.2024.07.008_bib0720","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/s41409-021-01385-9","article-title":"A novel TBI free conditioning protocol for haploidentical transplant in acquired aplastic anemia: (FluCAB-Prime)","volume":"56","author":"Iftikhar","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.008_bib0725","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2007-03-081596","article-title":"Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia","volume":"110","author":"Schrezenmeier","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bulcan.2024.07.008_bib0730","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3324\/haematol.2011.054841","article-title":"Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups","volume":"97","author":"Bacigalupo","year":"2012","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.bulcan.2024.07.008_bib0735","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.bbmt.2016.01.012","article-title":"Comparing outcomes with bone marrow or peripheral blood stem cells as graft source for matched sibling transplants in severe aplastic anemia across different economic regions","volume":"22","author":"Kumar","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.008_bib0740","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjh.19236","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology Guideline","volume":"204","author":"Kulasekararaj","year":"2024","journal-title":"Br J Haematol"},{"issue":"1\u20132","key":"10.1016\/j.bulcan.2024.07.008_bib0745","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000318893","article-title":"Management of aplastic anemia: the role of systematic reviews and meta-analyses","volume":"125","author":"Gafter-Gvili","year":"2011","journal-title":"Acta Haematol"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.008_bib0750","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/bmt.2012.220","article-title":"Supportive care in severe and very severe aplastic anemia","volume":"48","author":"H\u00f6chsmann","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.008_bib0755","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjh.19236","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology Guideline","volume":"204","author":"Kulasekararaj","year":"2024","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.008_bib0760","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2141.1997.812721.x","article-title":"Pilot study of HLA alloimmunization after transfusion with pre-storage leucodepleted blood products in aplastic anaemia","volume":"97","author":"Killick","year":"1997","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.008_bib0765","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2141.1990.tb06375.x","article-title":"Pretransfused patients with severe aplastic anaemia exhibit high numbers of cytotoxic T lymphocyte precursors probably directed at non-HLA antigens","volume":"76","author":"Kaminski","year":"1990","journal-title":"Br J Haematol"},{"issue":"1s","key":"10.1016\/j.bulcan.2024.07.008_bib0770","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.bulcan.2018.08.016","article-title":"[Transfusion in autologous and allogenic hematopoietic stem cell transplant: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]","volume":"106","author":"Giraud","year":"2019","journal-title":"Bull Cancer"},{"issue":"2s","key":"10.1016\/j.bulcan.2024.07.008_bib0775","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.bulcan.2023.03.004","article-title":"[Transfusion management and immuno-hematological follow-up after allogeneic hematopoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]","volume":"111","author":"Xhaard","year":"2024","journal-title":"Bull Cancer"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.008_bib0780","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/vox.12489","article-title":"Patient outcomes and amotosalen\/UVA-treated platelet utilization in massively transfused patients","volume":"112","author":"Nussbaumer","year":"2017","journal-title":"Vox Sang"},{"issue":"12","key":"10.1016\/j.bulcan.2024.07.008_bib0785","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3324\/haematol.2009.010231","article-title":"Granulocyte transfusions in severe aplastic anemia: an eleven-year experience","volume":"94","author":"Quillen","year":"2009","journal-title":"Haematologica"},{"issue":"2s","key":"10.1016\/j.bulcan.2024.07.008_bib0790","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.bulcan.2023.05.007","article-title":"[Vaccination of allogeneic haematopoietic stem cell transplant recipients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]","volume":"111","author":"Conrad","year":"2024","journal-title":"Bull Cancer"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.008_bib0795","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.patbio.2013.07.002","article-title":"[Social connection: a report of the SFGM-TC on the maintaining social and family connections during Hematopoietic Stem Cell Transplantation]","volume":"61","author":"Rohrlich","year":"2013","journal-title":"Pathol Biol"},{"issue":"2s","key":"10.1016\/j.bulcan.2024.07.008_bib0800","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.bulcan.2023.03.025","article-title":"[Allogeneic hematopoietic stem cell transplantation and treatment with CAR-T cells - identification of psycho-social vulnerability factors: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]","volume":"111","author":"Polomeni","year":"2024","journal-title":"Bull Cancer"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.008_bib0805","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41409-022-01598-6","article-title":"Optimized cyclosporine starting dose may reduce risk of acute GvHD after allogeneic hematopoietic cell transplantation: a single-center cohort study","volume":"57","author":"H\u00e9ritier","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.008_bib0810","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2141.2007.06903.x","article-title":"Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up","volume":"140","author":"Saracco","year":"2008","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.008_bib0815","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbmt.2016.11.003","article-title":"Mixed T cell chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia using an alemtuzumab-containing regimen is shaped by persistence of recipient CD8T cells","volume":"23","author":"Grimaldi","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.bulcan.2024.07.008_bib0820","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41409-019-0442-3","article-title":"Eltrombopag for post-transplant cytopenias due to poor graft function","volume":"54","author":"Marotta","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.bulcan.2024.07.008_bib0825","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/bbmt.2001.v7.pm11669214","volume":"7","author":"Antin","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.008_bib0830","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.leu.2403692","article-title":"Full donor chimerism by day 30\u00a0after allogeneic peripheral blood progenitor cell transplantation is associated with a low risk of relapse in pediatric patients with hematological malignancies","volume":"19","author":"Lassaletta","year":"2005","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.bulcan.2024.07.008_bib0835","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jcma.2018.06.005","article-title":"Early achievement of full donor chimerism after allogeneic hematopoietic stem cell transplantation predicts lower relapse risk in patients with acute lymphoblastic leukemia","volume":"81","author":"Chen","year":"2018","journal-title":"J Chin Med Assoc"},{"issue":"11","key":"10.1016\/j.bulcan.2024.07.008_bib0840","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.humimm.2021.07.013","article-title":"A practical guide to chimerism analysis: review of the literature and testing practices worldwide","volume":"82","author":"Blouin","year":"2021","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.008_bib0845","doi-asserted-by":"crossref","first-page":"e0212708","DOI":"10.1371\/journal.pone.0212708","article-title":"Earlier relapse detection after allogeneic haematopoietic stem cell transplantation by chimerism assays: Digital PCR versus quantitative real-time PCR of insertion\/deletion polymorphisms","volume":"14","author":"Valero-Garcia","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bulcan.2024.07.008_bib0850","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","article-title":"Diagnosis and management of paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Parker","year":"2005","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bulcan.2024.07.008_bib0855","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.bbmt.2019.07.029","article-title":"Outcome of fludarabine-based conditioning in high-risk aplastic anemia patients undergoing matched related donor transplantation: a single-center study from Pakistan","volume":"25","author":"Chaudhry","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.008_bib0430","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2141.2012.09058.x","article-title":"How I manage aplastic anaemia in children","volume":"157","author":"Samarasinghe","year":"2012","journal-title":"Br J Haematol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455124002832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455124002832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T18:51:25Z","timestamp":1736275885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455124002832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0007455124002832"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2024.07.008","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aplasies m\u00e9dullaires s\u00e9v\u00e8res acquises dans les pays \u00e9mergents\u00a0: prise en charge d\u00e8s l\u2019indication de l\u2019allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques jusqu\u2019au suivi postgreffe (SFGM-TC)","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2024.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}